Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Huang Jane | CMO, Hematology | Jan 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Feb 02 04:49 PM | Huang Jane | CMO, Hematology | Jan 29 | Sale | 322.99 | 1,500 | 484,492 | 0 | Feb 02 04:49 PM | Liang Howard | CFO & Chief Strategy Officer | Jan 15 | Option Exercise | 6.50 | 12,600 | 81,900 | 12,600 | Jan 19 05:04 PM | Liang Howard | CFO & Chief Strategy Officer | Jan 15 | Sale | 344.90 | 12,600 | 4,345,689 | 0 | Jan 19 05:04 PM | Liang Howard | CFO & Chief Strategy Officer | Jan 14 | Option Exercise | 6.50 | 1,400 | 9,100 | 1,400 | Jan 19 05:04 PM | Liang Howard | CFO & Chief Strategy Officer | Jan 14 | Sale | 344.47 | 1,400 | 482,256 | 0 | Jan 19 05:04 PM | BAKER BROS. ADVISORS LP | Director | Jan 04 | Sale | 220.50 | 121,154 | 26,714,457 | 968,943 | Jan 06 06:32 PM | Huang Jane | CMO, Hematology | Dec 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Dec 30 04:34 PM | Huang Jane | CMO, Hematology | Dec 29 | Sale | 249.13 | 1,500 | 373,690 | 0 | Dec 30 04:34 PM | Liang Howard | CFO & Chief Strategy Officer | Dec 14 | Option Exercise | 0.87 | 1,497,200 | 1,300,000 | 1,573,715 | Dec 16 04:43 PM | Liang Howard | CFO & Chief Strategy Officer | Dec 14 | Sale | 229.04 | 91,900 | 21,048,454 | 0 | Dec 16 04:43 PM | BAKER BROS. ADVISORS LP | Director | Dec 04 | Sale | 220.50 | 1,511,546 | 333,295,893 | 979,003 | Dec 04 05:24 PM | Huang Jane | CMO, Hematology | Nov 30 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Dec 02 05:01 PM | Huang Jane | CMO, Hematology | Nov 30 | Sale | 267.82 | 1,500 | 401,723 | 0 | Dec 02 05:01 PM | Huang Jane | CMO, Hematology | Oct 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Nov 02 04:44 PM | Huang Jane | CMO, Hematology | Oct 29 | Sale | 300.06 | 1,500 | 450,093 | 0 | Nov 02 04:44 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Oct 16 | Sale | 320.00 | 5,000 | 1,600,000 | 0 | Oct 20 04:44 PM | Liang Howard | CFO & Chief Strategy Officer | Oct 05 | Option Exercise | 6.50 | 14,000 | 91,000 | 14,000 | Oct 07 04:50 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Oct 05 | Sale | 300.00 | 5,000 | 1,500,000 | 0 | Oct 07 04:56 PM | Wu Xiaobin | President & GM China | Oct 05 | Sale | 300.00 | 4,000 | 1,200,000 | 0 | Oct 07 04:52 PM | Liang Howard | CFO & Chief Strategy Officer | Oct 05 | Sale | 299.60 | 14,000 | 4,194,413 | 0 | Oct 07 04:50 PM | Huang Jane | CMO, Hematology | Sep 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Oct 01 04:52 PM | Huang Jane | CMO, Hematology | Sep 29 | Sale | 280.38 | 1,500 | 420,568 | 0 | Oct 01 04:52 PM | OYLER JOHN | Chief Executive Officer | Sep 29 | Sale | 280.82 | 23,303 | 6,544,030 | 0 | Sep 30 04:53 PM | OYLER JOHN | Chief Executive Officer | Sep 28 | Sale | 280.07 | 31,000 | 8,682,063 | 0 | Sep 30 04:53 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Sep 25 | Sale | 280.42 | 5,000 | 1,402,116 | 0 | Sep 29 04:59 PM | Wu Xiaobin | President & GM China | Sep 25 | Sale | 280.35 | 4,000 | 1,121,406 | 0 | Sep 29 04:57 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Sep 17 | Sale | 260.27 | 5,000 | 1,301,356 | 0 | Sep 21 04:53 PM | Wu Xiaobin | President & GM China | Sep 17 | Sale | 260.33 | 4,000 | 1,041,327 | 0 | Sep 21 04:50 PM | OYLER JOHN | Chief Executive Officer | Sep 16 | Sale | 254.77 | 27,275 | 6,948,807 | 0 | Sep 16 05:12 PM | OYLER JOHN | Chief Executive Officer | Sep 15 | Sale | 254.26 | 34,214 | 8,699,381 | 0 | Sep 16 05:12 PM | Liang Howard | CFO & Chief Strategy Officer | Sep 14 | Option Exercise | 6.50 | 14,000 | 91,000 | 14,000 | Sep 16 05:10 PM | OYLER JOHN | Chief Executive Officer | Sep 14 | Sale | 250.25 | 19,739 | 4,939,782 | 0 | Sep 16 05:12 PM | Liang Howard | CFO & Chief Strategy Officer | Sep 14 | Sale | 250.27 | 14,000 | 3,503,764 | 0 | Sep 16 05:10 PM | Huang Jane | CMO, Hematology | Sep 03 | Sale | 233.07 | 3,128 | 729,045 | 0 | Sep 08 04:44 PM | OYLER JOHN | Chief Executive Officer | Sep 02 | Sale | 229.22 | 27,807 | 6,374,024 | 0 | Sep 02 05:44 PM | OYLER JOHN | Chief Executive Officer | Sep 01 | Sale | 233.79 | 20,274 | 4,739,809 | 0 | Sep 02 05:44 PM | OYLER JOHN | Chief Executive Officer | Aug 31 | Sale | 240.86 | 12,961 | 3,121,765 | 0 | Sep 02 05:44 PM | Huang Jane | CMO, Hematology | Aug 28 | Option Exercise | 29.49 | 3,000 | 88,470 | 3,000 | Sep 01 04:41 PM | Huang Jane | CMO, Hematology | Aug 28 | Sale | 242.21 | 3,000 | 726,626 | 0 | Sep 01 04:41 PM | OYLER JOHN | Chief Executive Officer | Aug 21 | Sale | 240.19 | 40,788 | 9,796,775 | 0 | Aug 21 05:21 PM | OYLER JOHN | Chief Executive Officer | Aug 20 | Sale | 234.62 | 21,523 | 5,049,749 | 0 | Aug 21 05:21 PM | OYLER JOHN | Chief Executive Officer | Aug 19 | Sale | 234.56 | 29,866 | 7,005,265 | 0 | Aug 21 05:21 PM | OYLER JOHN | Chief Executive Officer | Aug 14 | Sale | 211.15 | 8,705 | 1,838,034 | 0 | Aug 14 05:30 PM | OYLER JOHN | Chief Executive Officer | Aug 13 | Sale | 214.48 | 14,443 | 3,097,762 | 0 | Aug 14 05:30 PM | Chen Timothy Yung-Cheng | Director | Aug 12 | Option Exercise | 31.59 | 2,897 | 91,516 | 2,897 | Aug 12 05:02 PM | OYLER JOHN | Chief Executive Officer | Aug 12 | Sale | 212.10 | 19,820 | 4,203,766 | 0 | Aug 14 05:30 PM | Chen Timothy Yung-Cheng | Director | Aug 12 | Sale | 212.00 | 2,897 | 614,165 | 0 | Aug 12 05:02 PM | Chen Timothy Yung-Cheng | Director | Aug 11 | Option Exercise | 31.59 | 1,903 | 60,116 | 1,903 | Aug 12 05:02 PM | Chen Timothy Yung-Cheng | Director | Aug 11 | Sale | 213.04 | 1,903 | 405,409 | 0 | Aug 12 05:02 PM | Chen Timothy Yung-Cheng | Director | Aug 10 | Option Exercise | 31.59 | 2,200 | 69,498 | 2,200 | Aug 12 05:02 PM | Chen Timothy Yung-Cheng | Director | Aug 10 | Sale | 214.04 | 2,200 | 470,886 | 0 | Aug 12 05:02 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Aug 10 | Sale | 211.06 | 4,000 | 844,229 | 0 | Aug 12 04:38 PM | OYLER JOHN | Chief Executive Officer | Aug 05 | Sale | 223.27 | 17,254 | 3,852,273 | 0 | Aug 05 05:43 PM | OYLER JOHN | Chief Executive Officer | Aug 04 | Sale | 220.43 | 15,383 | 3,390,951 | 0 | Aug 05 05:30 PM | OYLER JOHN | Chief Executive Officer | Aug 03 | Sale | 221.78 | 25,176 | 5,583,575 | 0 | Aug 05 05:30 PM | Huang Jane | CMO, Hematology | Jul 29 | Option Exercise | 94.95 | 3,000 | 284,835 | 3,000 | Jul 31 04:24 PM | Huang Jane | CMO, Hematology | Jul 29 | Sale | 209.93 | 3,000 | 629,787 | 0 | Jul 31 04:24 PM | OYLER JOHN | Chief Executive Officer | Jul 22 | Sale | 238.34 | 27,748 | 6,613,503 | 0 | Jul 22 06:22 PM | OYLER JOHN | Chief Executive Officer | Jul 21 | Sale | 251.83 | 26,413 | 6,651,695 | 0 | Jul 22 06:14 PM | OYLER JOHN | Chief Executive Officer | Jul 20 | Sale | 251.85 | 28,762 | 7,243,784 | 0 | Jul 22 06:14 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jul 20 | Sale | 251.31 | 12,000 | 3,015,740 | 0 | Jul 22 04:47 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jul 20 | Sale | 251.98 | 5,000 | 1,259,896 | 0 | Jul 22 04:47 PM | Wu Xiaobin | President & GM China | Jul 20 | Sale | 250.16 | 2,600 | 650,407 | 0 | Jul 21 04:50 PM | Wu Xiaobin | President & GM China | Jul 17 | Sale | 245.74 | 700 | 172,015 | 0 | Jul 21 04:50 PM | Wu Xiaobin | President & GM China | Jul 15 | Sale | 241.11 | 2,700 | 650,998 | 0 | Jul 15 05:14 PM | Wu Xiaobin | President & GM China | Jul 13 | Sale | 220.00 | 3,000 | 660,000 | 0 | Jul 15 05:14 PM | OYLER JOHN | Chief Executive Officer | Jul 08 | Sale | 201.39 | 17,529 | 3,530,206 | 0 | Jul 08 05:20 PM | Huang Jane | CMO, Hematology | Jul 07 | Option Exercise | 160.40 | 3,921 | 628,928 | 3,921 | Jul 09 04:43 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jul 07 | Sale | 200.00 | 6,000 | 1,200,000 | 0 | Jul 09 04:45 PM | Huang Jane | CMO, Hematology | Jul 07 | Sale | 200.00 | 3,921 | 784,200 | 0 | Jul 09 04:43 PM | OYLER JOHN | Chief Executive Officer | Jul 07 | Sale | 198.86 | 19,023 | 3,782,987 | 0 | Jul 08 05:20 PM | OYLER JOHN | Chief Executive Officer | Jul 06 | Sale | 197.11 | 17,362 | 3,422,262 | 0 | Jul 08 05:20 PM | OYLER JOHN | Chief Executive Officer | Jul 01 | Sale | 191.57 | 3,816 | 731,016 | 0 | Jul 01 04:43 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jul 01 | Sale | 190.75 | 4,847 | 924,572 | 0 | Jul 06 04:52 PM | Huang Jane | CMO, Hematology | Jun 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Jun 30 04:14 PM | OYLER JOHN | Chief Executive Officer | Jun 29 | Sale | 192.60 | 1,435 | 276,374 | 0 | Jul 01 04:43 PM | Liang Howard | CFO & Chief Strategy Officer | Jun 29 | Sale | 191.23 | 300 | 57,368 | 0 | Jul 01 04:38 PM | Huang Jane | CMO, Hematology | Jun 29 | Sale | 190.83 | 1,935 | 369,250 | 0 | Jun 30 04:14 PM | Huang Jane | CMO, Hematology | Jun 26 | Option Exercise | 160.40 | 2,079 | 333,472 | 2,079 | Jun 30 04:14 PM | Huang Jane | CMO, Hematology | Jun 26 | Sale | 200.29 | 2,079 | 416,397 | 0 | Jun 30 04:14 PM | OYLER JOHN | Chief Executive Officer | Jun 24 | Sale | 187.34 | 14,381 | 2,694,156 | 0 | Jun 24 08:23 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jun 23 | Sale | 186.38 | 6,000 | 1,118,298 | 0 | Jun 24 08:12 PM | OYLER JOHN | Chief Executive Officer | Jun 23 | Sale | 186.88 | 15,070 | 2,816,222 | 14,381 | Jun 24 08:23 PM | OYLER JOHN | Chief Executive Officer | Jun 22 | Sale | 182.43 | 10,281 | 1,875,605 | 29,451 | Jun 24 08:23 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jun 22 | Sale | 181.33 | 5,000 | 906,673 | 0 | Jun 24 08:12 PM | OYLER JOHN | Chief Executive Officer | Jun 10 | Sale | 175.07 | 900 | 157,563 | 0 | Jun 12 04:14 PM | Liang Howard | CFO & Chief Strategy Officer | Jun 08 | Sale | 170.84 | 453 | 77,391 | 0 | Jun 10 05:17 PM | Wu Xiaobin | President & GM China | Jun 08 | Sale | 170.83 | 2,800 | 478,317 | 0 | Jun 10 05:15 PM | Huang Jane | CMO, Hematology | Jun 08 | Sale | 170.84 | 631 | 107,800 | 0 | Jun 10 05:13 PM | Wang Xiaodong | Chair, Scientific Advisory Brd | Jun 08 | Sale | 170.91 | 6,000 | 1,025,455 | 0 | Jun 10 05:12 PM | Huang Jane | CMO, Hematology | May 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Jun 02 04:11 PM | Huang Jane | CMO, Hematology | May 29 | Sale | 163.86 | 1,500 | 245,784 | 0 | Jun 02 04:11 PM | Glazer Donald W. | Director | May 19 | Sale | 169.84 | 10,000 | 1,698,400 | 0 | May 21 04:08 PM | OYLER JOHN | Chief Executive Officer | May 01 | Sale | 141.43 | 4,635 | 655,537 | 0 | May 05 04:48 PM | Wu Xiaobin | President & GM China | May 01 | Sale | 141.33 | 7,024 | 992,711 | 0 | May 05 04:46 PM | Huang Jane | CMO, Hematology | Apr 29 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Apr 30 04:04 PM | Huang Jane | CMO, Hematology | Apr 29 | Sale | 162.30 | 1,500 | 243,450 | 0 | Apr 30 04:04 PM | Huang Jane | CMO, Hematology | Apr 16 | Option Exercise | 29.49 | 1,500 | 44,235 | 1,500 | Apr 17 04:04 PM | Huang Jane | CMO, Hematology | Apr 16 | Sale | 160.00 | 1,500 | 240,000 | 0 | Apr 17 04:04 PM |
|